[1]向姣姣,李国娟,杨通艳,等.肠道菌群与肥胖发病机制的研究[J].医学信息,2022,35(10):70-73.[doi:10.3969/j.issn.1006-1959.2022.10.017]
 XIANG Jiao-jiao,LI Guo-juan,YANG Tong-yan,et al.Study on Intestinal Flora and Pathogenesis of Obesity[J].Medical Information,2022,35(10):70-73.[doi:10.3969/j.issn.1006-1959.2022.10.017]
点击复制

肠道菌群与肥胖发病机制的研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年10期
页码:
70-73
栏目:
综述
出版日期:
2022-05-15

文章信息/Info

Title:
Study on Intestinal Flora and Pathogenesis of Obesity
文章编号:
1006-1959(2022)10-0070-04
作者:
向姣姣李国娟杨通艳
(南华大学附属南华医院内分泌科,湖南 衡阳 421000)
Author(s):
XIANG Jiao-jiaoLI Guo-juanYANG Tong-yanet al.
(Department of Endocrinology,the Affiliated Nanhua Hospital,Hengyang Medical School,University of South China,Hengyang 421000,Hunan,China)
关键词:
肥胖肠道菌群脂肪组织
Keywords:
ObesityIntestinal floraAdipose tissue
分类号:
R589
DOI:
10.3969/j.issn.1006-1959.2022.10.017
文献标志码:
A
摘要:
肥胖是由遗传因素、环境因素等多种因素相互作用所致,肥胖者往往存在肠道菌群紊乱的现象,但目前关于肠道菌群影响肥胖的具体机制尚无定论,可能涉及脂肪组织褐化、能量积累、炎症反应、短链脂肪酸、肠道屏障等。本文就肠道菌群影响肥胖的机制进行综述,以期进一步阐明二者的联系,为临床治疗肥胖提供参考。
Abstract:
Obesity is caused by the interaction of genetic factors, environmental factors and other factors. Obesity often has the phenomenon of intestinal flora disorder. However, the specific mechanism of intestinal flora affecting obesity is still unclear, which may involve adipose tissue browning, energy accumulation, inflammatory response, short chain fatty acids, intestinal barrier and so on. This article reviews the mechanism of intestinal flora affecting obesity, in order to further clarify the relationship between the two, and provide reference for clinical treatment of obesity.

参考文献/References:

[1]Dikaiou P,Bjorck L,Adiels M,et al.Obesity, overweight and risk for cardiovascular disease and mortality in young women[J].Eur J Prev Cardiol,2021,28(12):1351-1359.[2]Cani PD,Delzenne NM.The gut microbiome as therapeutic target[J].Pharmacol Ther,2011,130(2):202-212.[3]B?覿ckhed F,Ding H,Wang T,et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci U S A,2004,101(44):15718-15723.[4]Hou YP,He QQ,Ouyang HM,et al.Human Gut Microbiota Associated with Obesity in Chinese Children and Adolescents[J].Biomed Res Int,2017,2017:7585989.[5]Frost F,Storck LJ,Kacprowski T,et al.A structured weight loss program increases gut microbiota phylogenetic diversity and reduces levels of Collinsella in obese type 2 diabetics: A pilot study[J].PLoS One,2019,14(7):e0219489.[6]Goffredo M,Mass K,Parks EJ,et al.Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth[J].J Clin Endocrinol Metab,2016,101(11):4367-4376.[7]Yin T,Bayanjargal S,Fang B,et al.Lactobacillus plantarum Shinshu N-07 isolated from fermented Brassica rapa L.attenuates visceral fat accumulation induced by high-fat diet in mice[J].Benef Microbes,2020,11(7):655-667.[8]Suárez-Zamorano N,Fabbiano S,Chevalier C,et al.Microbiota depletion promotes browning of white adipose tissue and reduces obesity[J].Nat Med,2015,21(12):1497-1501.[9]Li B,Li L,Li M,et al.Microbiota Depletion Impairs Thermogenesis of Brown Adipose Tissue and Browning of White Adipose Tissue[J].Cell Rep,2019,26(10):2720-2737,e5.[10]Kou G,Li P,Hu Y,et al.Nobiletin activates thermogenesis of brown and white adipose tissue in high-fat diet-fed C57BL/6 mice by shaping the gut microbiota[J].FASEB J,2021,35(2):e21267.[11]Moreno-Navarrete JM,Serino M,Blasco-Baque V,et al.Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity [J].Mol Nutr Food Res,Epub 2017 Dec 29.[12]Fang C,Kim H,Yanagisawa L,et al.Gallotannins and Lactobacillus plantarum WCFS1 Mitigate High-Fat Diet-Induced Inflammation and Induce Biomarkers for Thermogenesis in Adipose Tissue in Gnotobiotic Mice[J].Mol Nutr Food Res,2019,63(9):e1800937.[13]Yoon Y,Kim G,Noh MG,et al.Lactobacillus fermentum promotes adipose tissue oxidative phosphorylation to protect against diet-induced obesity[J].Exp Mol Med,2020,52(9):1574-1586.[14]Wang P,Li D,Ke W,et al.Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice [J].Int J Obes (Lond),2020,44(1):213-225.[15]Virtue AT,McCright SJ,Wright JM,et al.The gut microbiota regulates white adipose tissue inflammation and obesity via a family of microRNAs[J].Sci Transl Med,2019,11(496):eaav1892.[16]Nam B,Kim SA,Park SD,et al.Regulatory effects of Lactobacillus plantarum HY7714 on skin health by improving intestinal condition[J].PLoS One,2020,15(4):e0231268.[17]Lee C,Kim BG,Kim JH,et al.Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner[J].Int Immunopharmacol,2017,51:47-56.[18]Yan H,Ajuwon KM.Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway[J].PLoS One,2017,12(6):e0179586.[19]Ali AM,El-Tawil OS,Al-Mokaddem AK,et al.Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by cannabinoid receptor 2 agonist (AM1241),aborts inflammation and progress of hepatic fibrosis induced by thioacetamide[J].Chem Biol Interact,2021,336:109398.[20]Wu Q,Ma Y,Liu Y,et al.CB2R agonist JWH-133 attenuates chronic inflammation by restraining M1 macrophage polarization via Nrf2/HO-1 pathway in diet-induced obese mice [J].Life Sci,2020,260:120102.[21]Dos-Santos-Pereira M,Guimaraes FS,Del-Bel E,et al.Cannabidiol prevents LPS-induced microglial inflammation by inhibiting ROS/NF-kappaB-dependent signaling and glucose consumption[J].Glia,2020,68(3):561-573.[22]Hagan T,Cortese M,Rouphael N,et al.Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans[J].Cell,2019,178(6):1313-1328,e13.[23]Whitt J,Woo V,Lee P,et al.Disruption of Epithelial HDAC3 in Intestine Prevents Diet-Induced Obesity in Mice[J].Gastroenterology,2018,155(2):501-513.[24]Diao H,Jiao AR,Yu B,et al.Gastric infusion of short-chain fatty acids can improve intestinal barrier function in weaned piglets[J].Genes Nutr,2019,14:4.[25]Liu J,Zhu H,Li B,et al.Beneficial effects of butyrate in intestinal injury J].J Pediatr Surg,2020,55(6):1088-1093.[26]Feng Y,Wang Y,Wang P,et al.Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy[J].Cell Physiol Biochem,2018,49(1):190-205.[27]Li C,Jones PM,Persaud SJ.Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas[J].Pharmacol Ther,2011,129(3):307-320.[28]Manca C,Boubertakh B,Leblanc N,et al.Germ-free mice exhibit profound gut microbiota-dependent alterations of intestinal endocannabinoidome signaling[J].J Lipid Res,2020,61(1):70-85.[29]Manca C,Shen M,Boubertakh B,et al.Alterations of brain endocannabinoidome signaling in germ-free mice[J].Biochim Biophys Acta Mol Cell Biol Lipids,2020,1865(12):158786.[30]Castonguay-Paradis S,Lacroix S,Rochefort G,et al.Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat[J].Sci Rep,2020,10(1):15975.[31]Chevalier G,Siopi E,Guenin-Mace L,et al.Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system[J].Nat Commun,2020,11(1):6363.[32]Yagin NL,Aliasgari F,Alizadeh M,et al.Comparison of endocannabinoids levels, FAAH gene polymorphisms, and appetite regulatory substances in women with and without binge eating disorder: a cross- sectional study[J].Nutr Res,2020,83:86-93.[33]Piccolo M,Claussen MC,Bluemel S,et al.Altered circulating endocannabinoids in anorexia nervosa during acute and weight-restored phases:A pilot study[J].Eur Eat Disord Rev,2020,28(1):46-54.[34]Liu J,Godlewski G,Jourdan T,et al.Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5’Adenosine Monophosphate-Activated Protein Kinase Signaling[J].Hepatology,2019,69(4):1535-1548.[35]Roger C,Buch C,Muller T,et al.Simultaneous Inhibition of Peripheral CB1R and iNOS Mitigates Obesity-Related Dyslipidemia Through Distinct Mechanisms[J].Diabetes,2020,69(10):2120-2132.[36]Jacouton E,Mach N,Cadiou J,et al.Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice[J].PLoS One,2015,10(10):e0138880.[37]Korecka A,de Wouters T,Cultrone A,et al.ANGPTL4 expression induced by butyrate and rosiglitazone in human intestinal epithelial cells utilizes independent pathways[J].Am J Physiol Gastrointest Liver Physiol,2013,304(11):G1025-G1037.[38]Culpepper T,Rowe CC,Rusch CT,et al.Three probiotic strains exert different effects on plasma bile acid profiles in healthy obese adults: randomised, double-blind placebo-controlled crossover study[J].Benef Microbes,2019,10(5):497-509.[39]Kim DJ,Yoon S,Ji SC,et al.Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction[J].Sci Rep,2018,8(1):11874.[40]Zhao L,Yang W,Chen Y,et al.A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome[J].J Clin Invest,2020,130(1):438-450.[41]Hui S,Liu Y,Huang L,et al.Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling[J].Int J Obes (Lond),2020,44(8):1678-1690.[42]Calderon G,McRae A,Rievaj J,et al.Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes[J].EBioMedicine,2020,55:102759.[43]Alex S,Lichtenstein L,Dijk W,et al.ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract[J].Histochem Cell Biol,2014,141(4):383-391.[44]Kijmanawat A,Panburana P,Reutrakul S,et al.Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial[J]. J Diabetes Investig,2019,10(1):163-170.[45]Rabiei S,Hedayati M,Rashidkhani B,et al.The Effects of Synbiotic Supplementation on Body Mass Index, Metabolic and Inflammatory Biomarkers, and Appetite in Patients with Metabolic Syndrome: A Triple-Blind Randomized Controlled Trial[J].J Diet Suppl,2019,16(3):294-306.

相似文献/References:

[1]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
 LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(10):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[2]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
 CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Medical Information,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[3]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
 FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Medical Information,2018,31(10):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[4]刘 静.利拉鲁肽联合基础胰岛素对初诊2型糖尿病合并肥胖患者 血糖控制及体质量指数的影响[J].医学信息,2018,31(13):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
 LIU Jing.Effect of Liraglutide Combined with Basal Insulin on Blood Glucose Control and Body Mass Index in Newly Diagnosed Type 2 Diabetes Patients with Obesity[J].Medical Information,2018,31(10):137.[doi:10.3969/j.issn.1006-1959.2018.13.040]
[5]张 慧,胡广越,殷 红.菌群干预与免疫治疗的研究进展[J].医学信息,2022,35(11):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
 ZHAHG Hui,HU Guang-yue,YIN Hong.Research Progress in Microbial Intervention and Immunotherapy[J].Medical Information,2022,35(10):54.[doi:10.3969/j.issn.1006-1959.2022.11.016]
[6]曾利文,陈 静,张 晔,等.多囊卵巢综合征患者的糖代谢特点分析[J].医学信息,2019,32(02):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
 ZENG Li-wen,CHEN Jing,ZHANG Ye,et al.Analysis of Characteristics of Glucose Metabolism in Patients with Polycystic Ovarian Syndrome[J].Medical Information,2019,32(10):103.[doi:10.3969/j.issn.1006-1959.2019.02.029]
[7]褚福行,李珊珊,李思琪,等.慢性牙周炎伴肥胖患者血清中IL-6、IL-18表达水平的研究[J].医学信息,2019,32(01):92.[doi:10.3969/j.issn.1006-1959.2019.01.028]
 CHU Fu-xing,LI Shan-shan,LI Si-qi,et al.Study on the Expression Levels of IL-6 and IL-18 in Serum of Patients with Chronic Periodontitis and Obesity[J].Medical Information,2019,32(10):92.[doi:10.3969/j.issn.1006-1959.2019.01.028]
[8]姜海燕.双歧杆菌四联活菌治疗对肝硬化患者肝功能、细胞因子及肠道菌群的影响[J].医学信息,2022,35(12):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
 JIANG Hai-yan.Effect of Quadruple Viable Bifidobacterium Treatment on Liver Function, Cytokines and Intestinal Flora in Patients with Liver Cirrhosis[J].Medical Information,2022,35(10):156.[doi:10.3969/j.issn.1006-1959.2022.12.038]
[9]左俊芳,刘沙沙,崔洪艳.妊娠期糖尿病高危因素及预防措施研究[J].医学信息,2022,35(17):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
 ZUO Jun-fang,LIU Sha-sha,CUI Hong-yan.Study on High Risk Factors and Preventive Measures of Gestational Diabetes Mellitus[J].Medical Information,2022,35(10):177.[doi:10.3969/j.issn.1006-1959.2022.17.048]
[10]程晴晴,李元海,夏晓琼,等.超声联合神经刺激仪臂丛神经干精准阻滞在肥胖患者上肢手术中的应用[J].医学信息,2019,32(19):94.[doi:10.3969/j.issn.1006-1959.2019.19.028]
 CHENG Qing-qing,LI Yuan-hai,XIA Xiao-qiong,et al.Application of Ultrasound Combined with Neurostimulator for Brachial Plexus Nerve Block in Upper Limb Surgery in Obese Patients[J].Medical Information,2019,32(10):94.[doi:10.3969/j.issn.1006-1959.2019.19.028]

更新日期/Last Update: 1900-01-01